XML 30 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
3 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Incentive Equity Awards
The activity related to the Company’s incentive equity awards for the three months ended September 30, 2014 consisted of the following:
 
Stock Options
 
Time-based
Restricted Stock Units
 
Performance-based
Restricted Stock Units
 
Number of
Options (d)
 
Weighted-
Average
Exercise
Price
 
Number
of Shares
 
Weighted-
Average
Grant
Date Fair
Value
 
Number
of Shares
 
Weighted-
Average
Grant
Date Fair
Value
Balances at July 1, 2014
9,847,291

 
$
23.73

 
1,866,408

 
$
25.69

 
662,282

 
$
26.30

Granted
26,260

 
40.67

 
28,220

 
38.47

 
38,294

 
30.23

Exercise of stock options (a)
(811,073
)
 
18.93

 

 

 

 

Vesting of restricted stock units (b)

 

 
(980
)
 
25.15

 
(5,210
)
 
23.30

Expired/forfeited
(5,698
)
 
17.67

 
(24,222
)
 
27.04

 
(839
)
 
27.25

Balances at September 30, 2014 (c)
9,056,780

 
$
24.21

 
1,869,426

 
$
25.87

 
694,527

 
$
26.53

_____________
(a)
Stock options exercised during the period of July 1, 2014 through September 30, 2014 had an intrinsic value of $18.4 million.
(b)
Time-based and performance-based restricted stock units that vested during the period of July 1, 2014 through September 30, 2014 had a fair value of $0.2 million
(c)
As of September 30, 2014, the Company's outstanding "in the money" stock options using the September 30, 2014 closing stock price of $41.63 (approximately 5.9 million shares) had an aggregate intrinsic value of $121.1 million. As of September 30, 2014, time-based restricted stock units and performance-based restricted stock units expected to vest using the September 30, 2014 share price of $41.63 (approximately 1.7 million and 0.7 million shares, respectively) had an aggregate intrinsic value of $72.2 million and $28.4 million, respectively.
(d)
Stock options outstanding as of September 30, 2014 have a weighted-average remaining contractual life of 5.7 years and 5.9 million stock options are exercisable.